Eli Lilly is now offering drive-through testing for the virus that causes COVID-19 for Indianapolis health care workers.

The number of people being tested for the coronavirus has been limited by national shortages in tests and days-long waits for results. Two companies in Indiana are working to increase public testing.

A new partnership financed by memorial funds endowed by Eli Lilly and Co.'s first black chemist has set its sights on preserving some of Indiana's significant African American landmarks.

The Commerce Department says the North Carolina location beat out Indianapolis and Philadelphia for the plant, which will in part produce injectable drugs to treat diabetes.

Indianapolis-based Eli Lilly announced Friday it will acquire California-based biopharmaceutical company Dermira for a little more than $1 billion.

After a report criticized Eli Lilly and Co. for not doing enough to make affordable insulin available, the company launched a campaign Thursday to raise awareness of their discount options.

The facility upgrades in automation and data analytics will be some of Lilly's most advanced manufacturing technologies, the company says.

Indianapolis-based Eli Lilly is challenging a new federal rule that would require drug companies to include prices in TV ads.

The Indianapolis drugmaker has begun selling its own generic version of Humalog U-100 under the chemical name insulin lispro. It will cost $137.35 per vial, or $265.20 for a package of five KwikPens.

Six Indiana organizations have pitched in to buy a new high-tech microscope. The nearly $9 million machine is a cryo-electron microscope that allows scientists to examine molecules at the atomic level.